These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2720988)
1. Indirect measurement of desferrioxamine and its chelated compounds aluminoxamine and ferrioxamine by Zeeman atomic absorption spectrometry. D'Haese PC; Lamberts LV; De Broe ME Clin Chem; 1989 May; 35(5):884-7. PubMed ID: 2720988 [TBL] [Abstract][Full Text] [Related]
2. Urinary and biliary excretion of aluminoxamine and ferrioxamine in dogs with various renal function. D'Haese PC; Lamberts LV; Verpooten GA; Vaneerdeweg W; Jurgens A; Arakelian S; Babloyan A; Digenis P; Tjalma W; De Broe ME Kidney Int; 1994 Jan; 45(1):76-84. PubMed ID: 8127024 [TBL] [Abstract][Full Text] [Related]
3. Low percentage of aluminoxamine and ferrioxamine in uremic serum after desferrioxamine administration. Menéndez-Fraga P; Fernández-Martín JL; Blanco-González E; Cannata-Andía JB Clin Chem; 1998 Jun; 44(6 Pt 1):1262-8. PubMed ID: 9625051 [TBL] [Abstract][Full Text] [Related]
4. Quantification of desferrioxamine, ferrioxamine and aluminoxamine by post-column derivatization high-performance liquid chromatography. Non-linear calibration resulting from second-order reaction kinetics. Kraemer HJ; Breithaupt H J Chromatogr B Biomed Sci Appl; 1998 Jun; 710(1-2):191-204. PubMed ID: 9686887 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of aluminoxamine and ferrioxamine and dose finding of desferrioxamine in haemodialysis patients. Verpooten GA; D'Haese PC; Boelaert JR; Becaus I; Lamberts LV; De Broe ME Nephrol Dial Transplant; 1992; 7(9):931-8. PubMed ID: 1328941 [TBL] [Abstract][Full Text] [Related]
6. Indirect micro-scale method for the determination of desferrioxamine and its aluminium and iron chelated forms in biological samples by atomic absorption spectrometry with electrothermal atomisation. Allain P; Mauras Y; Beaudeau G; Hingouet P Analyst; 1986 May; 111(5):531-3. PubMed ID: 3740423 [No Abstract] [Full Text] [Related]
7. Validated HPLC assay for iron determination in biological matrices based on ferrioxamine formation. Tesoro A; Novakovic J; Thiessen JJ; Spino M J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Sep; 823(2):177-83. PubMed ID: 16023418 [TBL] [Abstract][Full Text] [Related]
8. Estimation of statistical moments for desferrioxamine and its iron and aluminum chelates: contribution to optimisation of therapy in uremic patients. Andriani M; Nordio M; Saporiti E Nephron; 1996; 72(2):218-24. PubMed ID: 8684530 [TBL] [Abstract][Full Text] [Related]
9. High-performance liquid chromatography of deferoxamine and ferrioxamine: interference by iron present in the chromatographic system. Cramer SM; Nathanael B; Horváth C J Chromatogr; 1984 Jul; 295(2):405-11. PubMed ID: 6432830 [TBL] [Abstract][Full Text] [Related]
10. Removal of aluminoxamine and ferrioxamine by charcoal hemoperfusion and hemodialysis. Vasilakakis DM; D'Haese PC; Lamberts LV; Lemoniatou E; Digenis PN; De Broe ME Kidney Int; 1992 May; 41(5):1400-7. PubMed ID: 1614055 [TBL] [Abstract][Full Text] [Related]
11. Use of ultrafiltration and chromatography to assess aluminum speciation in serum after deferoxamine administration. Canteros-Picotto A; Fernández-Martín JL; Cannata-Andía JB Am J Kidney Dis; 2000 Nov; 36(5):969-75. PubMed ID: 11054353 [TBL] [Abstract][Full Text] [Related]
12. Ferrioxamine and its hexadentate iron-chelating metabolites in human post-desferal urine studied by high-performance liquid chromatography and fast atom bombardment mass spectrometry. Lehmann WD; Heinrich HC Anal Biochem; 1990 Feb; 184(2):219-27. PubMed ID: 2109548 [TBL] [Abstract][Full Text] [Related]
13. Quantifying Intranasally Administered Deferoxamine in Rat Brain Tissue with Mass Spectrometry. Kosyakovsky J; Witthuhn BA; Svitak AL; Frey WH; Hanson LR; Fine JM ACS Chem Neurosci; 2019 Nov; 10(11):4571-4578. PubMed ID: 31573798 [TBL] [Abstract][Full Text] [Related]
14. Estimation of aluminoxamine and ferrioxamine in plasma by high performance liquid chromatography. Hughes H; Hagen LE; Cameron EC; Sutton RA Clin Chim Acta; 1986 May; 157(1):115-20. PubMed ID: 3719992 [No Abstract] [Full Text] [Related]
15. Pharmacokinetics of desferrioxamine and of its iron and aluminum chelates in patients on peritoneal dialysis. Allain P; Chaleil D; Mauras Y; Varin MC; Ang KS; Cam G; Simon P Clin Chim Acta; 1988 Apr; 173(3):313-6. PubMed ID: 3383431 [TBL] [Abstract][Full Text] [Related]
16. The determination of ferric iron in plants by HPLC using the microbial iron chelator desferrioxamine E. Fernández V; Winkelmann G Biometals; 2005 Feb; 18(1):53-62. PubMed ID: 15865410 [TBL] [Abstract][Full Text] [Related]
17. An expedient reverse-phase high-performance chromatography (RP-HPLC) based method for high-throughput analysis of deferoxamine and ferrioxamine in urine. Arshad B; Iqbal T; Akram S; Mushtaq M Biomed Chromatogr; 2017 Feb; 31(2):. PubMed ID: 27503066 [TBL] [Abstract][Full Text] [Related]
18. Aluminum determination in biological fluids and dialysis concentrates via chelation with 8-hydroxyquinoline and solvent extraction/fluorimetry. Buratti M; Valla C; Pellegrino O; Rubino FM; Colombi A Anal Biochem; 2006 Jun; 353(1):63-8. PubMed ID: 16643833 [TBL] [Abstract][Full Text] [Related]
19. Kinetics of aluminoxamine and feroxamine chelates in dialysis patients. Canavese C; Gurioli L; D'Amicone M; Cardelli R; Caligaris F; Bongiorno P; Arnaud A; Mattiello G; Marchiori M Nephron; 1992; 60(4):411-7. PubMed ID: 1584315 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of desferrioxamine and ferrioxamine by high-performance liquid chromatography with amperometric detection. Glennon JD; Senior AT J Chromatogr; 1990 May; 527(2):481-9. PubMed ID: 2117617 [No Abstract] [Full Text] [Related] [Next] [New Search]